This site may require a log-in in the near future. We are constantly being swamped by AI agents. If they continue to take down the site, we will be changing to requiring logins to access any item.

Eubacteriales Family XIII. Incertae Sedis: NCBI 543314, [family]

Back to details

| Clostridiales Family XIII. Incertae Sedis

  1. Mucosal Surfaces:

    • Verrucomicrobia bacteria are often found in mucosal surfaces, including the gastrointestinal tract. Their presence in the mucosal environment suggests potential interactions with the host's immune system and other microorganisms in these regions.
  2. Akkermansia muciniphila:

    • One of the well-studied genera within Verrucomicrobia is Akkermansia. Akkermansia muciniphila is a species known to inhabit the mucus layer of the intestinal lining. Research has suggested that A. muciniphila may have positive effects on metabolic health, including its potential role in maintaining mucosal integrity and modulating metabolic pathways.
  3. Mucus Degradation:

    • Some members of Verrucomicrobia, including Akkermansia species, are specialized in utilizing mucin, a component of the protective mucus layer in the gut. This ability to degrade mucin may influence the gut environment and the interactions between the microbiota and the host.
  4. Metabolic Health:

    • Akkermansia muciniphila has been associated with metabolic health benefits in preclinical studies. It has been linked to improvements in glucose metabolism, insulin sensitivity, and lipid metabolism. However, the translation of these findings to human health is an area of ongoing investigation.
  5. Immunomodulation:

    • Verrucomicrobia bacteria may play a role in immunomodulation, influencing the host's immune response. The interactions between Verrucomicrobia and the immune system are complex and context-dependent.
  6. Associations with Disease:

    • Altered abundances of Verrucomicrobia have been observed in studies of the gut microbiota in various health conditions. Changes in the relative abundance of Verrucomicrobia, including increases or decreases, have been reported in conditions such as inflammatory bowel disease (IBD), obesity, and diabetes. However, the specific contributions of Verrucomicrobia to these conditions are still being explored.

Other Sources for more information:

Legend

Eubacteriales Family XIII. Incertae Sedis impacts on other bacteria of the same rank

R2SlopeTax NameParent Chart
0.37436270713806150.6555760502815247LachnospiraceaeParent Taxa
0.3657827675342560.618162989616394ChristensenellaceaeParent Taxa
0.357061892747879030.6378743648529053ErysipelotrichaceaeParent Taxa
0.353561550378799440.6341038942337036EubacteriaceaeParent Taxa
0.31328043341636660.5985933542251587PeptostreptococcaceaeParent Taxa
0.311874479055404660.5636367201805115TreponemataceaeParent Taxa
0.29935345053672790.5399907231330872GemmatimonadaceaeParent Taxa
0.288506060838699340.5551921725273132AtopobiaceaeParent Taxa
0.286173433065414430.5379666090011597AcholeplasmataceaeParent Taxa
0.28012380003929140.5046929121017456AcetobacteraceaeParent Taxa
0.27962535619735720.5220967531204224MaliibacteriaceaeParent Taxa
0.27816337347030640.5094577670097351CytophagaceaeParent Taxa
0.275130331516265870.5620133280754089OscillospiraceaeParent Taxa
0.262489587068557740.5276748538017273BruguierivoracaceaeParent Taxa

Other bacteria of the same rank impacting Eubacteriales Family XIII. Incertae Sedis

R2SlopeTax NameParent Chart
0.349554777145385740.6173096299171448ChristensenellaceaeParent Taxa
0.337998986244201660.607925534248352TreponemataceaeParent Taxa
0.33584380149841310.5991880297660828AtopobiaceaeParent Taxa
0.30819436907768250.614137589931488MaliibacteriaceaeParent Taxa
0.30716904997825620.625419557094574AcetobacteraceaeParent Taxa
0.299378991127014160.5137268900871277LachnospiraceaeParent Taxa
0.27592369914054870.501893162727356ErysipelotrichaceaeParent Taxa
0.27423116564750670.5010384917259216EubacteriaceaeParent Taxa
0.25320267677307130.4789353609085083PeptostreptococcaceaeParent Taxa

Explanations /Info /Descriptions are influenced by Large Language Models and may not be accurate and include some hallucinations.Please report any to us for correction.

Copyright 2016 - 2025 Lassesen Consulting, LLC[2007], DBA, Microbiome Prescription All rights served.   Permission to data scrap or reverse engineer is explicitly denied to all users.U.S.Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA   Use of data on this site is prohibited except under written license.There is no charge for individual personal use.Use for any commercial applications or research requires a written license.   Caveat emptor: Analysis and suggestions are based on modelling(and thus infererence ) based on studies.The data sources are usually given for those that wish to consider alternative inferences.theories and models.   Inventions /Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not in strict compliance with Personal Health Information Laws. [216.73.216 ]